

Can't find Apremilast (Otezla) in stock? Here are practical tools and tips to locate your prescription, including specialty pharmacy options and Medfinder.
You've jumped through the hoops — doctor's appointment, prior authorization, insurance approval — and now you just need to actually get your Apremilast. But finding this medication in stock isn't always straightforward.
Apremilast (brand name Otezla) is a specialty medication for plaque psoriasis, psoriatic arthritis, and oral ulcers from Behçet's disease. Because of how it's classified and distributed, tracking it down requires a different approach than picking up a regular prescription.
Here's exactly how to find Apremilast in stock near you — with practical tools and tips that actually work.
Medfinder is designed specifically for situations like this. Instead of calling pharmacy after pharmacy, you can search for Apremilast availability in your area from one place.
Here's how it works:
This is especially helpful because Apremilast is a specialty medication that most retail pharmacies don't carry. Medfinder can point you toward specialty pharmacies and other sources that actually stock it.
Unlike common medications, Apremilast is almost always dispensed through specialty pharmacies. These are pharmacies that focus on complex, high-cost medications and offer additional patient support services.
Common specialty pharmacies that dispense Apremilast include:
Your insurance plan likely has a preferred specialty pharmacy. Call the number on the back of your insurance card and ask which specialty pharmacy is in-network for Apremilast. Using the preferred pharmacy can mean faster processing and lower copays.
Specialty pharmacies typically:
The tradeoff is that orders can take 3-7 business days to process and ship, so plan ahead before you run out.
One of the most common reasons patients struggle to find Apremilast in stock is waiting too long to reorder. With specialty pharmacy processing times, prior authorization renewals, and shipping, you should start the refill process at least 7-10 days before your current supply runs out.
Here are some timing tips:
If you're hitting walls despite trying these approaches, here are additional options:
Amgen's patient support program can help navigate access issues. They can:
Call 1-833-44AMGEN (1-833-442-6436) for assistance.
Some dermatologists and rheumatologists keep Otezla starter packs in their office. If you need medication urgently while waiting for your specialty pharmacy order, ask if your doctor has samples available.
If access continues to be a problem, talk to your doctor about alternatives to Apremilast. Depending on your condition, options like Methotrexate, Deucravacitinib (Sotyktu), or biologic medications may be available and easier to access.
Sometimes the issue isn't stock — it's cost. If your copay is too high, explore savings programs for Apremilast that could bring your out-of-pocket cost down significantly.
It helps to understand why Apremilast is harder to find than a typical medication:
None of this means you can't get it — it just means the process requires more planning than a typical prescription.
Finding Apremilast in stock is more about navigating the specialty pharmacy system than searching shelf by shelf. Start with Medfinder to check availability, work with your insurance-preferred specialty pharmacy, and plan your refills well in advance.
If you're dealing with access issues, Amgen SupportPlus (1-833-442-6436) is your best resource for getting connected to the medication you need. And remember — the earlier you start the process, the less likely you are to face a gap in your treatment.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.